Evidence map›Paper›PMID 40860158›Full record

ArticleTheranostics2025

Co-delivery of targeted hypoallergens and resiquimod powders using silk fibroin microneedles for effective allergen-specific immunotherapy.

Zhen Wang, Xiaolei Lu, Lingzhi Wu, Xin Jiang, Wei Wang, Yahua Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Rethinking asthma therapy, part 2: transdermal strategies for adjunct asthma and allergy treatments.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhen WangDepartment of Pharmacy, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, 314000, China.
Xiaolei LuDepartment of Pharmacy, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, 314000, China.
Lingzhi WuDepartment of Pharmacy, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, 314000, China.
Xin JiangDepartment of Pharmacy, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, 314000, China.
Wei WangCollege of Materials and Textile Engineering, Jiaxing University, Jiaxing 314001, China.
Yahua WangDepartment of Pharmacy, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, 314000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllergensDesensitization, ImmunologicDrug Delivery SystemsFibroinsImidazolesAdministration, CutaneousAnimalsDendritic CellsDisease Models, AnimalFemaleMiceMice, Inbred BALB CNeedlesOvalbuminPowdersSkinAllergensFibroinsImidazolesOvalbuminPowdersresiquimodallergen-specific immunotherapy (AIT)allergic asthmamannan-ovalbumin (mOVA) conjugatespowder-laden microneedlesresiquimod (R848)

Identifiers

PMID40860158
PMCPMC12374546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.